Cargando…

A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy

Flavocoxid is a blended extract containing baicalin and catechin with potent antioxidant and anti-inflammatory properties due to the inhibition of the cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) enzymes, nuclear factor-κB (NF-κB), tumor necrosis factor (TNF)-alpha, and the mitogen-activated prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vita, Gian Luca, Sframeli, Maria, Licata, Norma, Bitto, Alessandra, Romeo, Sara, Frisone, Francesca, Ciranni, Annamaria, Pallio, Giovanni, Mannino, Federica, Aguennouz, M’Hammed, Rodolico, Carmelo, Squadrito, Francesco, Toscano, Antonio, Messina, Sonia, Vita, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830560/ https://www.ncbi.nlm.nih.gov/pubmed/33467104 http://dx.doi.org/10.3390/brainsci11010115

Ejemplares similares

Hippo signaling pathway is altered in Duchenne muscular dystrophy
por: Vita, Gian Luca, et al.
Publicado: (2018)

Activation of NF-kB pathway in Duchenne muscular dystrophy: relation to age
por: MESSINA, S., et al.
Publicado: (2011)

Flavocoxid, a Nutraceutical Approach to Blunt Inflammatory Conditions
por: Bitto, Alessandra, et al.
Publicado: (2014)

Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients
por: Bianchi, Laura, et al.
Publicado: (2021)

Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects
por: Russo, Massimo, et al.
Publicado: (2020)

Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis
por: Vita, Gian Luca, et al.
Publicado: (2020)

Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance
por: Oreto, Lilia, et al.
Publicado: (2020)

Rare among Rare: Phenotypes of Uncommon CMT Genotypes
por: Gentile, Luca, et al.
Publicado: (2021)

Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity
por: Micali, Antonio, et al.
Publicado: (2018)

Clinical, morphological and genetic features of a cohort of late onset GSD II patients: typical and atypical presentations
por: Barca, E, et al.
Publicado: (2013)

Is it the right time for an infant screening for Duchenne muscular dystrophy?
por: Vita, Gian Luca, et al.
Publicado: (2020)

Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant
por: Burnett, Bruce P., et al.
Publicado: (2011)

Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
por: Bitto, Alessandra, et al.
Publicado: (2012)

Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
por: Bitto, Alessandra, et al.
Publicado: (2023)

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)
por: Parisi, Daniela, et al.
Publicado: (2018)

Combined Treatment with Polynucleotides and Hyaluronic Acid Improves Tissue Repair in Experimental Colitis
por: Pallio, Giovanni, et al.
Publicado: (2020)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)

Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
por: Rodolico, Carmelo, et al.
Publicado: (2020)

Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis
por: Pallio, Giovanni, et al.
Publicado: (2020)

A Rare Case of Flavocoxid-Induced Pulmonary Fibrosis
por: Drekolias, Dimitrios, et al.
Publicado: (2020)

Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet
por: Mannino, Federica, et al.
Publicado: (2022)

Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy
por: Mercuri, Eugenio, et al.
Publicado: (2016)

The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
por: Irrera, Natasha, et al.
Publicado: (2020)

The 6 Minute Walk Test and Performance of Upper Limb in Ambulant Duchenne Muscular Dystrophy Boys
por: Pane, Marika, et al.
Publicado: (2014)

Beneficial Effects of Polydeoxyribonucleotide (PDRN) in an In Vitro Model of Fuchs Endothelial Corneal Dystrophy
por: Ceravolo, Ida, et al.
Publicado: (2022)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Oxidative Stress: Harms and Benefits for Human Health
por: Pizzino, Gabriele, et al.
Publicado: (2017)

MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells
por: Pallio, Giovanni, et al.
Publicado: (2021)

Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity
por: Mannino, Federica, et al.
Publicado: (2021)

PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation
por: Irrera, Natasha, et al.
Publicado: (2020)

Genetic modifiers of respiratory function in Duchenne muscular dystrophy
por: Bello, Luca, et al.
Publicado: (2020)

Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy
por: Gentile, Luca, et al.
Publicado: (2021)

Genetic modifiers of upper limb function in Duchenne muscular dystrophy
por: Sabbatini, Daniele, et al.
Publicado: (2022)

Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
por: Galeano, Mariarosaria, et al.
Publicado: (2021)

Biglycan Involvement in Heart Fibrosis: Modulation of Adenosine 2A Receptor Improves Damage in Immortalized Cardiac Fibroblasts
por: Scuruchi, Michele, et al.
Publicado: (2023)

Role of Inflammation and Oxidative Stress Mediators in Gliomas
por: Conti, Alfredo, et al.
Publicado: (2010)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
por: Mazzone, Elena Stacy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mvb3ukngctorbb11i2mmb65evj